Report
Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma
Journal of Community Hospital Internal Medicine Perspectives, v 8(4), pp 244-245
04 Jul 2018
PMID: 30181837
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Autoimmune hemolytic anemia (AIHA) is a condition associated with an extensive differential diagnosis that includes lymphoid malignancies. Although AIHA occurs in about 10-25% of patients with chronic lymphocytic leukemia, it is also reported to occur in all of the other lymphoid subtypes. In this article, we report a case of recurrent AIHA in a 67-year-old woman with two acute episodes of hemolysis separated by 3 years of hematologic remission. Both episodes were severe enough to require blood transfusion, oral steroids, and rituximab. Bone marrow biopsy and immunophenotyping using flow cytometry done during both admissions confirmed the presence of splenic marginal zone lymphoma.
Metrics
1 Record Views
Details
- Title
- Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma
- Creators
- Oreoluwa Oladiran - Reading HospitalRashmi Dhital - Reading HospitalAnthony Donato - Reading Hospital
- Publication Details
- Journal of Community Hospital Internal Medicine Perspectives, v 8(4), pp 244-245
- Publisher
- Taylor & Francis
- Number of pages
- 2
- Resource Type
- Report
- Language
- English
- Academic Unit
- Medicine (Graduate); General Internal Medicine
- Web of Science ID
- WOS:000442628600018
- Other Identifier
- 991022161833704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Hematology